AI assistant
Sending…
Onconetix, Inc. — Director's Dealing 2022
Aug 29, 2022
35411_dirs_2022-08-29_fa411c20-2aab-4dac-afbd-a8100424346c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-08-25
Reporting Person: Cincinnati Cornerstone Investors BWV I, LLC (10% Owner)
Reporting Person: Cincinnati Cornerstone Capital LLC (Manager-Cinti Cornerstone Inv.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-25 | Common Stock | J | 500000 | — | Disposed | 3111201 | Direct |
Footnotes
F1: Distribution of Issuer Common Stock pursuant to a pro rata distribution by Cincinnati Cornerstone Investors BWV I, LLC.
F2: Cincinnati Cornerstone Capital, LLC, as the manager and a member of Cincinnati Cornerstone Investors BWV I, LLC, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities, except to the extent of its pecuniary interest therein.
More from Onconetix, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Mar 30
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Feb 12
Regulatory Filings
2026
Feb 12
Regulatory Filings
2026
Feb 9